Pharma Manufacturing & Quality Management China 2012 is Upcoming
PR Newswire SHANGHAI, Aug. 22, 2012
-- Effective Implementation of Quality Management System to Enhance New GMP Compliance SHANGHAI,Aug. 22, 2012/PRNewswire/ --Pharma Manufacturing & Quality ManagementChina2012,organized by CPhI Conferences, will be held on 6th - 7th NovemberinSuzhou,China. China's New GMP Regulation has come into force on1st March, 2011. There are only 154 out of 5000 pharmaceutical companies in China which passed the new GMP inspection by the end of 2011. Manufacturing sterile drug products such as blood products, vaccines and other injectable drug products will be required to comply by31 December, 2013, while all other facilities will have until31 December, 2015. Over 5000 Chinese pharmaceutical companies are facing challenges in the context of "hardware and software" updates as below:
How to understand the relations between the new GMP and drug quality management system How to implement practical measures to build quality management system How to deal with the deviation and change during production process How to proceed with process verification on sterile drug products and improve quality How to keep the balance between quality and cost
Pharma Manufacturing & Quality ManagementChina2012will gather 120+decision makers from bothgovernment institutionsand pharmaceutical companiesto discuss hot topics includingquality management system,API manufacturing,solid dosage form productionandsterile drug products. It will provide an interactive communication platform for professionals in the pharmaceutical industry to benchmark your business and technology against 'best in class' and ensure that you have the tools you need to form a coherent and logical strategy. For more information, pleaseclick hereor send an email to askconference@ubm.com. Website: www.pharma-manufacturing-china.com Media Contact Ms. Tracy Cui Tel: +86-21-6157-3919 Fax: +86-21-6157-7299 Email: tracy.cui@ubm.com